Virtual Medicinal Product (VMP) - Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets Start Date 20-02-2025 End Date
Previous Name Previous Name Generic Genvoya 150mg/150mg/200mg/10mg tablets Start Date 21-12-2015 End Date 19-02-2025

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
Other

Codes

ATC Code
J05AR18
BNF Codes
  • BNF code 05030100
SNOMED Codes
Code Start Date End Date
31145211000001103 21-12-2015

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Cobicistat Based on Ingredient Substance 150 mg
Elvitegravir Based on Ingredient Substance 150 mg
Emtricitabine Based on Ingredient Substance 200 mg
Tenofovir alafenamide fumarate Based on Base Substance Tenofovir alafenamide 10 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
30 tablet